Randomized trial of interferon beta-1a with or without ribavirin in Asian patients with chronic hepatitis C
Author:
Publisher
Wiley
Subject
Hepatology
Reference30 articles.
1. Approach to the Patient with Chronic Hepatitis C Virus Infection
2. Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
3. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
4. American Gastroenterological Association Medical Position Statement on the Management of Hepatitis C
5. Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection;Microbial Pathogenesis;2021-09
2. The Removal of HBV in Plasma by Extracorporeal Immunoadsorption from Plasma: A Potential Therapy of Hepatitis B Patients;BioMed Research International;2018-12-23
3. The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C;Liver International;2018-01-25
4. Disease-modifying therapies and infectious risks in multiple sclerosis;Nature Reviews Neurology;2016-03-04
5. Patient-reported Outcomes in Asian Patients With Chronic Hepatitis C Treated With Ledipasvir and Sofosbuvir;Medicine;2016-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3